Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001645470-20-000002)

Filing Details

Accession Number:: 0001645470-20-000002
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-01-24 11:56:57
Reporting Period:: 2019-12-10

Accepted Time:: 2020-01-24 11:56:57
Original Submission Date:: 2019-12-31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1528172	Endonovo Therapeutics Inc.	ENDV	Pharmaceutical Preparations (2834)	452552528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645470	Brian Alan Collier	6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-10	2,000	$0.00	25,414,997	No	4	P	Direct
Common Stock	Acquisiton	2019-12-10	1,000	$0.00	25,415,997	No	4	P	Direct
Common Stock	Acquisiton	2019-12-11	1,000	$0.00	25,416,997	No	4	P	Direct
Common Stock	Acquisiton	2019-12-11	100	$0.00	25,417,097	No	4	P	Direct
Common Stock	Acquisiton	2019-12-12	1,000	$0.00	25,418,097	No	4	P	Direct
Common Stock	Acquisiton	2019-12-16	500	$0.00	25,418,597	No	4	P	Direct
Common Stock	Acquisiton	2019-12-20	100	$1.50	25,519	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Reflects a 1000 to 1 reverse split